{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:58Z","timestamp":1791910378884,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":395,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jacc.2015.12.047","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T14:16:25Z","timestamp":1457360185000},"page":"1227-1234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Fasting or Nonfasting Lipid Measurements"],"prefix":"10.1016","volume":"67","author":[{"given":"Steven L.","family":"Driver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ty J.","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Clary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.12.047_bib1","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM196701192760305","article-title":"Fat transport in lipoproteins\u2014an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.047_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2015.12.047_bib4","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.047_bib5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jacc.2015.01.043","article-title":"Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC\/AHA Guidelines","volume":"65","author":"Martin","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib6","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jacc.2014.05.056","article-title":"Accuracy of statin assignment using the 2013 AHA\/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging","volume":"64","author":"Johnson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.114.010001","article-title":"Prognostic value of\u00a0fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight\u00a0from the National Health and Nutrition Examination Survey III (NHANES-III)","volume":"130","author":"Doran","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.047_bib8","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.12.047_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/clinchem\/48.3.489","article-title":"Performance of four homogeneous direct methods for LDL-cholesterol","volume":"48","author":"Miller","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2015.12.047_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/clinchem\/47.1.124","article-title":"Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C plus assay?","volume":"47","author":"Ord\u00f3\u00f1ez-Llanos","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2015.12.047_bib11","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2013.07.045","article-title":"Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids)","volume":"62","author":"Elshazly","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1464-5491.2008.02519.x","article-title":"Variability of lipids in patients with type 2 diabetes taking statin treatment: implications for target setting","volume":"25","author":"Sathyapalan","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacc.2015.12.047_bib13","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.metabol.2012.05.009","article-title":"Lipids seasonal variability in type 2 diabetes","volume":"61","author":"Bardini","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.jacc.2015.12.047_bib14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.12.047_bib15","doi-asserted-by":"crossref","first-page":"e44347","DOI":"10.1371\/journal.pone.0044347","article-title":"Women up, men down: the clinical impact of replacing the Framingham Risk Score with the Reynolds Risk Score in the United States population","volume":"7","author":"Tattersall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2015.12.047_bib16","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","article-title":"Familial lipoprotein disorders in patients with\u00a0premature coronary artery disease","volume":"85","author":"Genest","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.047_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ahj.2014.09.001","article-title":"Reducing the burden of disease and death from familial hypercholesterolemia: a call to action","volume":"168","author":"Knowles","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.12.047_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacl.2007.07.006","article-title":"Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B","volume":"1","author":"Sniderman","year":"2007","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2015.12.047_bib19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2015.12.047_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11883-014-0440-2","article-title":"Hyperlipoproteinemia type 3: the forgotten phenotype","volume":"16","author":"Hopkins","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2015.12.047_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.annder.2008.07.062","article-title":"[Orange skin and xanthomas associated with lycopenaemia in a setting of type III dyslipoproteinemia]","volume":"136","author":"Royer","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jacc.2015.12.047_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1373\/clinchem.2004.047001","article-title":"Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations","volume":"51","author":"Blom","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2015.12.047_bib23","series-title":"Endotext [online]","article-title":"Metabolic Syndrome","author":"Lam","year":"2000"},{"key":"10.1016\/j.jacc.2015.12.047_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","article-title":"Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?","volume":"102","author":"Lemieux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.047_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2015.12.047_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1503\/cmaj.090092","article-title":"Is diagnosing metabolic syndrome a uniquely simple way to predict incident type 2 diabetes mellitus?","volume":"180","author":"Reaven","year":"2009","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jacc.2015.12.047_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.5993\/AJHB.36.4.9","article-title":"Impact of diagnosing metabolic syndrome on risk perception","volume":"36","author":"Jumean","year":"2012","journal-title":"Am J Health Behav"},{"key":"10.1016\/j.jacc.2015.12.047_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.047_bib29","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1016\/j.amepre.2012.12.010","article-title":"Working with the YMCA to implement the Diabetes Prevention Program","volume":"44","author":"Ackermann","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2015.12.047_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1186\/1471-2458-12-1041","article-title":"A\u00a0smartphone-supported weight loss program: design of the ENGAGED randomized controlled trial","volume":"12","author":"Pellegrini","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2015.12.047_bib31","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.111.088591","article-title":"Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study","volume":"125","author":"Mora","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.047_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2014.10.053","article-title":"Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL","volume":"65","author":"Kohli","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib33","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.jacc.2015.03.543","article-title":"The remnants of residual risk","volume":"65","author":"Joshi","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial","volume":"51","author":"Miller","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib35","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2015.03.544","article-title":"Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins","volume":"65","author":"Schwartz","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib36","doi-asserted-by":"crossref","first-page":"g4356","DOI":"10.1136\/bmj.g4356","article-title":"Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance","volume":"349","author":"Rabar","year":"2014","journal-title":"Br Med J"},{"key":"10.1016\/j.jacc.2015.12.047_bib37","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Eckel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib38","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.047_bib39","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2011.12.035","volume":"59","author":"Mora","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib40","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.amjcard.2014.08.009","article-title":"Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy","volume":"114","author":"Puri","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.047_bib41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/ATVBAHA.114.304477","article-title":"Atheroma progression in hyporesponders to statin therapy","volume":"35","author":"Kataoka","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.12.047_bib42","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","article-title":"Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial. Full coverage for preventive medications after myocardial infarction","volume":"365","author":"Choudhry","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.047_bib43","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.047_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ajcn\/67.1.31","article-title":"Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults","volume":"67","author":"Dubois","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2015.12.047_bib45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1373\/clinchem.2015.241752","article-title":"Identifying an optimal cutpoint for the diagnosis of hypertriglyceridemia in the nonfasting state","volume":"61","author":"White","year":"2015","journal-title":"Clin Chem"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716001315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716001315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T12:30:38Z","timestamp":1655209838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716001315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0735109716001315"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.047","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fasting or Nonfasting Lipid Measurements","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}